Naprosyn (Naproxen)

Naproxen works by inhibiting the cyclooxygenase (COX‑1 and COX‑2) enzymes, which are essential for the production of prostaglandins. Prostaglandins mediate pain, inflammation, and fever, so their reduction leads to decreased symptoms in affected tissues.

The specific dose of Naprosyn is determined by the prescribing healthcare professional based on the individual’s condition, severity, age, and other medical factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical advice.

Safety of naproxen in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit outweighs the risk, and always under the guidance of a qualified healthcare provider.

To order Naprosyn, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Both naproxen and ibuprofen belong to the NSAID class and share similar mechanisms of COX inhibition. Naproxen generally has a longer half‑life, allowing less frequent dosing, while ibuprofen may have a quicker onset. Choice between them depends on clinical response, dosing convenience, and individual risk profiles.

Naprosyn should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure they are out of reach of children.

Naprosyn is taken orally, usually with a full glass of water. It can be taken with or without food; however, taking it with food or milk may lessen stomach irritation. Swallow tablets whole; do not crush or chew unless specifically instructed by a healthcare professional.

Serious risks include gastrointestinal bleeding or ulcer perforation, cardiovascular events such as heart attack or stroke, severe skin reactions like Stevens‑Johnson syndrome, significant liver enzyme elevation, and acute kidney injury. Patients should seek immediate medical attention if they notice signs such as black stools, chest pain, sudden rash, or reduced urine output.

Naprosyn should be avoided in individuals with known hypersensitivity to naproxen or other NSAIDs, those with active gastrointestinal ulceration or bleeding, patients with severe heart failure, recent myocardial infarction, or uncontrolled hypertension, and in anyone who is pregnant in the third trimester without medical supervision.